Question

In: Biology

The Huntington’s Disease (HD) gene (HTT) is located on chromosome 4, and the age of onset...

The Huntington’s Disease (HD) gene (HTT) is located on chromosome 4, and the age of onset of the condition is closely related to the repeat-expansion size within this gene. Recent research shows that a particular variant on chromosome 15 acts as a modifier for the condition. Someone with a repeat expansion in their HTT gene as well as this modifier variant will develop HD symptoms approximately six years earlier than someone without this modifier variant. A woman with Huntington’s disease has one copy of this modifier variant, and has a child with an unaffected man, who also has one copy of this modifier variant.

a) What are the chances their child has inherited the HD expansion, but not the modifier variant?

b) What are the chances their child has inherited the HD expansion and at least one copy of the modifier variant?

Solutions

Expert Solution

The gene for HD, which is an autosomal dominant condition, is on chromosome 4 and the gene for the modifier is ion chromosome 15. So they are not linked and would be inherited independently. So if the woman has a genotype of Hh for HD and Mm for the modifier variant ( so she is HhMm) and the man is hhMm ( since he does not have HD but has one copy of the modifier). the possible gametes are HM, Hm, hM, hm( woman), and hM, hm( man).

hm

hM

HM

HhMm

HhMM

hM

hhMm

hhMM

Hm

Hhmm

HhMm

hm

hhmm

hhMm

a) So, chances that their child has inherited HD expansion and not the variant is the probability of Hhmm offspring, which is 1/8 ( red-colored) or 0.125.

b) there are 3 instances when the gene for HD expansion (H) and the modifier (M, one or two copies) are present (green colored). So, the probability for HD gene along with one or two copies of the modifier ( at least one copy includes instances of one or more copies of the modifier) is 3/8 0r 0.375.


Related Solutions

Another disease caused by a mutation in a single gene is Huntington’s disease (HD), an autosomal...
Another disease caused by a mutation in a single gene is Huntington’s disease (HD), an autosomal dominant condition. It is caused by mutations in a gene required for normal nerve cell function. The mutations cause abnormal proteins to be produced which “stick” together and accumulate in nerve cells, eventually interfering with normal cell operations. Suggest two ways you could treat the disease by targeting the translation step for the HD protein and justify why each approach might be effective.
Huntington’s disease (HD) is a fatal neurodegenerative disorder. As the disease progresses, HD patients exhibit abnormalities...
Huntington’s disease (HD) is a fatal neurodegenerative disorder. As the disease progresses, HD patients exhibit abnormalities in both of their efferent motor divisions. Interestingly, HD patients seem to have impairments in their ability to regulate Mean Arterial Pressure. For example, you are treating a patient who always gets lightheaded and/or faints immediately upon standing. The issue is so pronounced that they literally sleep standing up! (a) (2 points) What change in MAP occurs for someone who stands up? Please use...
Develop a case study/report on the Huntington disease and the gene for this disease is HTT...
Develop a case study/report on the Huntington disease and the gene for this disease is HTT gene. When you are developing the case study, start it from the DNA variant(a specific variant of the HTT gene) to the phenotype of the diseased patient. The case report you should include the following: 1) the Genomic coordinates of the variant of the disease. 2) Transcript level coordinates of the variant if within mRNA (immature or mature) 2a) 5’-UTR, 3’, intron, exon, or...
Develop a case study/report on the Huntington disease and the gene for this disease is HTT...
Develop a case study/report on the Huntington disease and the gene for this disease is HTT gene. When you are developing the case study, start it from the DNA variant(a specific variant of the HTT gene) to the phenotype of the diseased patient. The case report you should include the following: 1) If the gene exonic, type of variant (SNP of CNV) and resultant changes in protein or protein level. 2) Is the variant found in the non-coding region and...
Develop a case study/report on the Huntington disease and the gene for this disease is HTT...
Develop a case study/report on the Huntington disease and the gene for this disease is HTT gene. When you are developing the case study, start it from the DNA variant(a specific variant of the HTT gene) to the phenotype of the diseased patient. The case report you should include the following: . 1a) Transcript level coordinates of the variant if within mRNA (immature or mature) 1b) 5’-UTR, 3’, intron, exon, or splice site as examples 2c) If exonic, type of...
Develop a case study/report on the Huntington disease and the gene for this disease is HTT...
Develop a case study/report on the Huntington disease and the gene for this disease is HTT gene. When you are developing the case study, start it from the DNA variant(a specific variant of the HTT gene) to the phenotype of the diseased patient. The case report you should include the following: 1) Description of genomic/epigenomic/cytogenetic/transcriptomic/proteomic characterization/detection of disease (how is the genetic cause determined) 2) Give a flow chart for determination of the genetic cause at the clinical level (i.e....
19. For Huntington’s disease, expansion of trinucleotide repeat occurs within the ORF causing the HTT protein...
19. For Huntington’s disease, expansion of trinucleotide repeat occurs within the ORF causing the HTT protein to have many repeats of the amino acid glutamine, which in turn, causes the mutant protein to be toxic to neurons. Fragile X syndrome is also a trinucleotide repeat disease. How is the FMR1gene (or its gene product) affected in the case of fragile X syndrome? 20. Classify the mutation that causes sickle cell anemia three different ways. 21. Describe a cellular process that...
19. For Huntington’s disease, expansion of trinucleotide repeat occurs within the ORF causing the HTT protein...
19. For Huntington’s disease, expansion of trinucleotide repeat occurs within the ORF causing the HTT protein to have many repeats of the amino acid glutamine, which in turn, causes the mutant protein to be toxic to neurons. Fragile X syndrome is also a trinucleotide repeat disease. How is the FMR1gene (or its gene product) affected in the case of fragile X syndrome? 20. Classify the mutation that causes sickle cell anemia three different ways. 21. Describe a cellular process that...
Based on the Huntington disease which has the gene of HTT gene. Answer the following questions:...
Based on the Huntington disease which has the gene of HTT gene. Answer the following questions: 1a) Is the gene exonic or not?, 1b) what  type of variant (SNP of CNV) and if the resultant changes in protein or protein level. 2) Is the variant found in the non-coding region and also is it involved in transcriptional regulation, if so describe the proposed pathway. 3) Draw a three-generation pedigree with at least 15 family members. 4) A narrative describing the pedigree...
Based on the Huntington disease which has the gene of HTT gene. Answer the following questions:...
Based on the Huntington disease which has the gene of HTT gene. Answer the following questions: 1)Description of genomic/epigenomic/cytogenetic/transcriptomic/proteomic characterization/detection of disease (how is the genetic cause determined) 2) Give a flow chart for determination of the genetic cause at the clinical level (i.e. phenomic upon the first presentation to the clinic to confirmation of genetic disorder).
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT